Rigel Pharmaceuticals | Ativos





Ativos Alterar Data
Agenus USD 233.89M 48.67M 2025-09
Amgen USD 90.59B 445M 2025-12
Anika Therapeutics USD 189.44M 1.76M 2025-09
Arrowhead Research USD 1.6B 218.89M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
BioMarin Pharmaceutical USD 7.61B 158.53M 2025-09
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Celldex Therapeutics USD 648.44M 43.97M 2025-09
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
Eli Lilly USD 114.94B 14.01B 2025-09
Halozyme Therapeutics USD 2.22B 167.33M 2025-09
Heron Therapeutics USD 248.95M 16.86M 2025-09
Intrexon USD 73.16M 77.88M 2024-06
Ionis Pharmaceuticals USD 3.03B 47.96M 2025-09
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Ligand Pharmaceuticals USD 1.48B 528.17M 2025-09
MacroGenics USD 270.76M 25.34M 2025-09
Neurocrine Biosciences USD 4.27B 375.9M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Ultragenyx Pharmaceutical USD 1.19B 115.82M 2025-09
Veracyte USD 1.37B 23.68M 2025-09


Rigel Pharmaceuticals Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.